PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Sever, Peter S.
TI  - ASCOT-LLA: Statin Legacy Felt with Reduced Non-CV Death Eight Years after Trial End?
DP  - 2011 Nov 01
TA  - MD Conference Express
PG  - 22--23
VI  - 11
IP  - 10
4099  - http://mdc.sagepub.com/content/11/10/22.short
4100  - http://mdc.sagepub.com/content/11/10/22.full
AB  - Prior treatment with atorvastatin is associated with a reduction in the risk of all-cause mortality compared with placebo 8 years after the early termination of the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm [ASCOT-LLA] and 11 years after initial randomization, according to new findings from a long-term follow-up study.